Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease

Figure 2 Immunohistochemical staining for nuclear factor-κB protein expression (SP, magnification × 200). A: The control group; B: The model group at the end of the 6^th week; C: The model group at the end of the 10^th week; D: The model group at the end of the 14^th week; E: The intervention group at the end of the 14^th week.